NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics.
NovAccess Global, Inc. is building long-term shareholder value through intelligent acquisition of assets in clinical stage research and development, balanced with medical assets in market. We bring together the best technological assets and the best scientific and executive team to accelerate taking these assets to market. We also promote growth of products in the market and utilize our expert Board of Advisors to increase the market share of our assets. We seek to have rapid growth through acquisition and organic growth. We are focused on cancer technologies that fit into our business plan but are also responsive to uniquely focused opportunities.
Novel immunotherapeutic approaches to treat brain tumors and neurological diseases
Novel diagnostic tools for earlier and more accurate detection and staging of cancer
AI-based platform and block chain technologies for a more personalized, patient-centered approach to improving the quality of life for cancer and neurological patients
NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics.
NovAccess Global, Inc. is building long-term shareholder value through intelligent acquisition of assets in clinical stage research and development, balanced with medical assets in market. We bring together the best technological assets and the best scientific and executive team to accelerate taking these assets to market. We also promote growth of products in the market and utilize our expert Board of Advisors to increase the market share of our assets. We seek to have rapid growth through acquisition and organic growth. We are focused on cancer technologies that fit into our business plan but are also responsive to uniquely focused opportunities.
Novel immunotherapeutic approaches to treat brain tumors and neurological diseases
Novel diagnostic tools for earlier and more accurate detection and staging of cancer
AI-based platform and block chain technologies for a more personalized, patient-centered approach to improving the quality of life for cancer and neurological patients
Provide your email below to receive updates.
Provide your email below to receive updates.